Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Search

Page Path

HOME
Search

4

A Case of Complete Regression of Hepatocellular Carcinoma during Administration of COX-2 Inhibitor

Hae Jung Song, M.D., Yun Soo Kim, M.D. Chang Hee Han, M.D., Jae Young Jang, M.D., Jung Hoon Kim, M.D. Young Koog Cheon, M.D., Young Seok Kim, M.D., Jong Ho Moon, M.D., Young Deok Cho, M.D., Chan Sup Shim, M.D., Kui Hyang Kwon, M.D. and Boo Sung Kim, M.D.

Clin Mol Hepatol. 2006;12(3):449-454. Published online January 1, 2000

View: 2522 Download: 19

1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Impact Factor

8.9
First decision

09 Days

Publication after acceptance

04 Days

*Last 12 months

MOST VIEWED (Last 6 months)

Viewed By 5446	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5427	MAFLD: How is it different from NAFLD?
Viewed By 5302	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3975	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3975	Global incidence and prevalence of nonalcoholic fatty liver disease

+more

MOST CITED (2022-2024)

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 77	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

+more

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051 FAX: +82-2-703-0071 E-mail: kasl@kams.or.kr

COUNTER

TODAY : 2102

TOTAL : 1801033